Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px
Document › Details

Biocrates Life Sciences AG. (3/18/14). "Press Release: AbsoluteIDQ p180 by Biocrates Life Sciences AG. Cutting-edge Metabolomics Test Kit Made in Austria Helps Develop the World’s First Metabolite based Blood Test to Predict Alzheimer’s Disease". Innsbru

Organisation Organisation Biocrates Life Sciences AG
Products Product AbsoluteIDQ® p180 Kit
  Product 2 Alzheimer test (blood)
Person Person Klocker, Martina (Biocrates 201110 Marketing Manager)
     


A US research team has succeeded in developing the world's first blood test capable of predicting, with 90% accuracy, the risk of Alzheimer's disease 2-3 years before it has actually become clinically manifest. The findings, published in Nature Medicine, were generated using the validated AbsoluteIDQ® p180 test kit by Austrian BIOCRATES Life Sciences AG, a leading developer of innovative metabolomics solutions.


A team of researchers in Georgetown, Washington DC, and Rochester, New York, has developed the world's first blood test capable of predicting Alzheimer's disease. The first-of-its-kind study, recently published in Nature Medicine, used the AbsoluteIDQ® p180 test kit by BIOCRATES Life Sciences AG, a leading Austrian biotech company specialized in targeted metabolite quantification.

Alzheimer's disease currently affects more than 35 million individuals worldwide, and this figure is expected to increase to up to 150 million by 2050. A cure for Alzheimer's disease is currently not available, but early detection could contribute to substantially improving the situation of affected individuals. While biomarkers have long been expected to provide important clues to the early causes of Alzheimer's disease, current biomarkers are either invasive, time-consuming, or costly. The team around Mapstone and Federoff now discovered that a set of 10 lipids from peripheral blood predicts the development of mild cognitive impairment or Alzheimer's disease with over 90% accuracy and 2-3 years in advance. Although it will take some time to develop test versions fit for use in doctors' offices, the findings by Mapstone et al. are an impressive example of the power of metabolomics in diagnosis and biomarker discovery.

AbsoluteIDQ p180 provides extensive metabolic information from a single targeted assay, quantifying 186 analytes from 5 substance classes in a high-throughput manner. It features the advanced proprietary MetIDQ™ software solution, requires minute sample volumes (10 µL), and is suitable for use with a wide range of biological samples, making it an excellent choice for researchers looking for a cost-effective solution to measure endogenous metabolites under quality-controlled conditions. The AbsoluteIDQ kits by BIOCRATES have been successfully applied in many different areas, including diabetes, nephrology, sepsis, and CNS disorders, in both clinical and pharmaceutical research.


About BIOCRATES

BIOCRATES Life Sciences AG offers unique solutions for targeted, quantitative and quality-controlled metabolic phenotyping ('deep phenotyping'). The company's mass spectrometry-based assays are marked by unprecedented accuracy and precision, thus providing a comprehensive and predictive understanding of phenotypes and metabolic pathways. BIOCRATES metabolomics solutions set a new level of standardized data processing, exchange, and storage, which can readily meet the rigorous demands of various disciplines such as life sciences, personalized medicine, clinical research, nutrition research, and pharmaceutical drug development.
For more information, please go to www.biocrates.com.


BIOCRATES Life Sciences AG
Martina Klocker
Martina.Klocker@biocrates.com
Phone: +43 (0) 512 579823

   
Record changed: 2016-01-10

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Biocrates Life Sciences AG


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px